Nove regained his weight loss leg in the doll arena – but Lily is coming
Listen to the article 4 minutes This audio is automatically generated. Please let us know if you have feedback. After losing significant ground to rival Eli Lilly in the GLP-1 space over the past two years, Novo Nordisk is defending the field it now dominates — oral therapies. But as Lilly prepares to launch an … Read more